Chous Eye Care Associates, Inc. - Medicare Optometrist in Tacoma, WA

Chous Eye Care Associates, Inc. is a medicare enrolled "Optometrist" provider in Tacoma, Washington. Their current practice location is 6720 Regents Blvd, Tacoma, Washington. You can reach out to their office (for appointments etc.) via phone at (253) 565-9403.

Chous Eye Care Associates, Inc. is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Chous Eye Care Associates, Inc. is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1114080884.

Contact Information

Chous Eye Care Associates, Inc.
6720 Regents Blvd,
Tacoma, WA 98466-5400
(253) 565-9403
(253) 564-5637



Healthcare Provider's Profile

Full NameChous Eye Care Associates, Inc.
TypeFacility
SpecialityOptometrist
Location6720 Regents Blvd, Tacoma, Washington
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1114080884
  • Provider Enumeration Date: 12/17/2006
  • Last Update Date: 08/22/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 1355334517
  • Enrollment ID: O20040405001376

Medical Identifiers

Medical identifiers for Chous Eye Care Associates, Inc. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1114080884NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Chous Eye Care Associates, Inc. acts as a billing entity for following providers:
Provider NameAlan P Chous
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1851391866
PECOS PAC ID: 0941352389
Enrollment ID: I20090716000375

News Archive

New driving guideline for people with Alzheimer's disease

The American Academy of Neurology has issued a new guideline to help determine when people with Alzheimer's disease or another type of dementia should stop driving. The guideline is published in the April 12, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology, and was presented at the American Academy of Neurology's Annual Meeting in Toronto.

FDA clears Toshiba's CT Myocardial Perfusion technology

To improve cardiac diagnoses with simplified dose reduction technology, Toshiba announces the FDA clearance of its industry-exclusive CT Myocardial Perfusion capability. Available on Toshiba's AquilionTM ONE and Aquilion ONE ViSION Edition CT systems.

EntreMed announces data from ENMD-2076 Phase 2 study in platinum-resistant ovarian cancer

EntreMed, Inc., a clinical stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the final data for the primary endpoint of progression free survival rate at 6 months for its Phase 2 study with ENMD-2076 in platinum-resistant ovarian cancer patients.

Researchers explore range of potential new fuel sources in nature

On the long and difficult road toward a carbon-neutral source of transportation fuels, the U.S. Department of Energy is pursuing a diversified approach. This effort involves exploring a range of potential new fuel sources in nature: from plants that may serve as cellulosic feedstocks-fast-growing trees and perennial grasses on land-to oil-producing organisms in aquatic and other environments, such as algae and bacteria.

Ticagrelor reduces heart attacks and strokes for patients with diabetes

In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study, a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke.

Read more Medical News

› Verified 3 days ago

Provider NameElizabeth K Chous
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1760482772
PECOS PAC ID: 1254324312
Enrollment ID: I20120220000828

News Archive

New driving guideline for people with Alzheimer's disease

The American Academy of Neurology has issued a new guideline to help determine when people with Alzheimer's disease or another type of dementia should stop driving. The guideline is published in the April 12, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology, and was presented at the American Academy of Neurology's Annual Meeting in Toronto.

FDA clears Toshiba's CT Myocardial Perfusion technology

To improve cardiac diagnoses with simplified dose reduction technology, Toshiba announces the FDA clearance of its industry-exclusive CT Myocardial Perfusion capability. Available on Toshiba's AquilionTM ONE and Aquilion ONE ViSION Edition CT systems.

EntreMed announces data from ENMD-2076 Phase 2 study in platinum-resistant ovarian cancer

EntreMed, Inc., a clinical stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the final data for the primary endpoint of progression free survival rate at 6 months for its Phase 2 study with ENMD-2076 in platinum-resistant ovarian cancer patients.

Researchers explore range of potential new fuel sources in nature

On the long and difficult road toward a carbon-neutral source of transportation fuels, the U.S. Department of Energy is pursuing a diversified approach. This effort involves exploring a range of potential new fuel sources in nature: from plants that may serve as cellulosic feedstocks-fast-growing trees and perennial grasses on land-to oil-producing organisms in aquatic and other environments, such as algae and bacteria.

Ticagrelor reduces heart attacks and strokes for patients with diabetes

In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study, a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Chous Eye Care Associates, Inc. is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Chous Eye Care Associates, Inc.
25300 Lake Wilderness Country Club Dr Se,
Maple Valley, WA 98038-6003

Ph: (425) 432-5929
Chous Eye Care Associates, Inc.
6720 Regents Blvd,
Tacoma, WA 98466-5400

Ph: (253) 565-9403

News Archive

New driving guideline for people with Alzheimer's disease

The American Academy of Neurology has issued a new guideline to help determine when people with Alzheimer's disease or another type of dementia should stop driving. The guideline is published in the April 12, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology, and was presented at the American Academy of Neurology's Annual Meeting in Toronto.

FDA clears Toshiba's CT Myocardial Perfusion technology

To improve cardiac diagnoses with simplified dose reduction technology, Toshiba announces the FDA clearance of its industry-exclusive CT Myocardial Perfusion capability. Available on Toshiba's AquilionTM ONE and Aquilion ONE ViSION Edition CT systems.

EntreMed announces data from ENMD-2076 Phase 2 study in platinum-resistant ovarian cancer

EntreMed, Inc., a clinical stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the final data for the primary endpoint of progression free survival rate at 6 months for its Phase 2 study with ENMD-2076 in platinum-resistant ovarian cancer patients.

Researchers explore range of potential new fuel sources in nature

On the long and difficult road toward a carbon-neutral source of transportation fuels, the U.S. Department of Energy is pursuing a diversified approach. This effort involves exploring a range of potential new fuel sources in nature: from plants that may serve as cellulosic feedstocks-fast-growing trees and perennial grasses on land-to oil-producing organisms in aquatic and other environments, such as algae and bacteria.

Ticagrelor reduces heart attacks and strokes for patients with diabetes

In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study, a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke.

Read more News

› Verified 3 days ago


Optometrist in Tacoma, WA

Cascade Pacific Eyecare
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1314 72nd St E, Suite D, Tacoma, WA 98404
Phone: 253-531-5535    
Dr. Herbert Alden Blake, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: Optometry Clinic, Madigan Army Medical Center, Tacoma, WA 98431
Phone: 253-968-2790    Fax: 253-968-4677
Northwest Vision Care, Inc.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 4502 S Steele St Ste 100, Tacoma, WA 98409
Phone: 253-471-7123    Fax: 253-475-1104
Dr. Diana H. P. Nguyen, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 4051 Tacoma Mall Blvd, Tacoma, WA 98409
Phone: 253-476-2874    
Nathan J Ho, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 2913 S 38th St, Ste B3, Tacoma, WA 98409
Phone: 253-473-1050    
Dr. James Daniel Kaastrup I, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 4502 S Steele St, Suite 200, Tacoma, WA 98409
Phone: 253-471-8369    Fax: 253-475-7767
Sharon L Williams, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1708 Yakima Ave, Ste 100, Tacoma, WA 98405
Phone: 253-502-5965    Fax: 253-593-8410

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.